BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8315432)

  • 1. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma.
    Berinstein NL; Reis MD; Ngan BY; Sawka CA; Jamal HH; Kuzniar B
    J Clin Oncol; 1993 Jul; 11(7):1344-52. PubMed ID: 8315432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment.
    Berinstein NL; Jamal HH; Kuzniar B; Klock RJ; Reis MD
    Leukemia; 1993 Jan; 7(1):113-9. PubMed ID: 8418370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
    Ha CS; Cabanillas F; Lee MS; Besa PC; McLaughlin P; Cox JD
    Clin Cancer Res; 1997 Feb; 3(2):215-9. PubMed ID: 9815675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.
    Johnson PW; Price CG; Smith T; Cotter FE; Meerabux J; Rohatiner AZ; Young BD; Lister TA
    J Clin Oncol; 1994 Apr; 12(4):798-805. PubMed ID: 8151322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
    Ha CS; Tucker SL; Lee MS; McLaughlin P; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):727-32. PubMed ID: 11172955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
    Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
    Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
    Chen ZY; Zhou XY; Zhang TM; Hong XN; Yin JL; Hu XC; Shi DR
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):183-8. PubMed ID: 19615255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible influence of clinical stage and type of treatment in the persistence of residual circulating t(14;18)-positive cells in follicular lymphoma patients.
    Colleoni GW; Duarte LC; Kerbauy FR; Noguti MA; Felix RS; De Oliveira JS; Figueiredo MS; Alves AC
    Leuk Lymphoma; 2004 Mar; 45(3):539-45. PubMed ID: 15160916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and quantification of MBR/JH2 t(14;18) BCL-2 gene rearrangement in follicular lymphoma using a combined real-time polymerase chain reaction assay.
    Csernák E; Tóth E; Melegh Z; Schneider T; Rosta A; Szentirmay Z
    Haematologica; 2006 Jun; 91(6):858-9. PubMed ID: 16704964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma.
    Lambrechts AC; Hupkes PE; Dorssers LC; van't Veer MB
    Blood; 1993 Oct; 82(8):2510-6. PubMed ID: 8400298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment.
    Pappa VI; Wilkes S; Salam A; Young BD; Lister TA; Rohatiner AZ
    Bone Marrow Transplant; 1998 Sep; 22(6):553-8. PubMed ID: 9758342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
    Kornacker M; Kornacker B; Schmitt C; Leo E; Ho AD; Hensel M
    Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases.
    Dölken G; Illerhaus G; Hirt C; Mertelsmann R
    J Clin Oncol; 1996 Apr; 14(4):1333-44. PubMed ID: 8648392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma.
    Tsimberidou AM; Jiang Y; Ford RJ; Lichtiger B; Medeiros LJ; McLaughlin P; Cabanillas F; Sarris AH
    Leuk Lymphoma; 2002 Aug; 43(8):1589-98. PubMed ID: 12400601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells.
    Pichert G; Schmitz SF; Hess U; Cerny T; Cogliatti SB; Betticher D; Stupp R; Schmitter D; Stahel RA; Ghielmini M
    Clin Lymphoma; 2001 Mar; 1(4):293-7. PubMed ID: 11707844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity.
    Goodlad JR; Krajewski AS; Batstone PJ; McKay P; White JM; Benton EC; Kavanagh GM; Lucraft HH;
    Am J Surg Pathol; 2002 Jun; 26(6):733-41. PubMed ID: 12023577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide clonospecific probes directed against the junctional sequence of t(14;18): a new tool for the assessment of minimal residual disease in follicular lymphomas.
    Galoin S; al Saati T; Schlaifer D; Huynh A; Attal M; Delsol G
    Br J Haematol; 1996 Sep; 94(4):676-84. PubMed ID: 8826892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
    Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
    Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.